Phaseolotoxin [NVf(N'-sulfo-diaminophosphinyl)-ornithyl-alanyl-homoarginineI produced by Pseudomonas syringae pv. phaseolicola, the bean halo blight pathogen, is a potent inhibitor of ornithine carbamoyltransferase (OCT). Inhibition of OCT in infected plants leads to chlorosis and growth inhibition. A genomic cosmid clone, pHK120, containing a 25-kb fragment of DNA from a wild-type strain of P. syringae pv. phaseolicola restores toxin production in Tox-mutants. TnS mutagenesis of pHK120 and marker exchange of pHK120::TnS plasmids in the wild-type strain resulted in the isolation of 39 chromosomal mutants that harbor TnS insertions at known positions. Toxin bioassays revealed that 28 of the mutants, with TnS insertions distributed throughout the insert of pHK120, were Tox-, indicating that a functional locus for toxin production in each mutant was inactivated. Complementation analysis was done by testing for toxin production strains that carried a genomic TnS at one location and a plasmid-borne TnS at another location (pair complementation). Pair complementation analysis of nine marker exchange mutants and a random genomic TnS mutant revealed that there are a minimum of eight toxin loci (phtA through phtH) in pHK120. Mutants carrying Tn5 insertions in the phtA, phtD, and phtF loci were complemented by deletion subclones containing fragments from pHK120; mutants carrying Tn5 insertions in the phtC locus were partially complemented by a subclone, and mutants carrying TnS insertions in the phtB, phtE, phtG, and phtH loci were not complemented by any of the available subclones. A comparison of the insert from pHK120 with that from pRCP17, a clone reported previously
Phaseolotoxin is an extracellular, nonspecific, chlorosisinducing phytotoxin produced (at 18 to 22°C) by Pseudomonas syringae pv. phaseolicola, the causative agent of halo blight of beans (Phaseolus vulgaris L.). Phaseolotoxin [N8(N'-sulfo-diaminophosphinyl)-ornithyl-alanyl-homoarginine] (23) and its nonpeptide degradation product octicidin [N8(N'-sulfo-diaminophosphinyl)-ornithine] (21) inhibit a key enzyme, ornithine carbamoyltransferase (OCT), in the arginine biosynthetic pathway (21, 29) in vitro as well as in bean plants infected with toxigenic strains of P. syringae pv. phaseolicola (19) . The inhibition of OCT in infected plants leads to chlorosis and growth inhibition.
Phytotoxins are produced by several bacterial pathogens, and although much is known about their chemical structures and their physiological and biochemical effects in diseased plants (20, 28) , little is known about the genetics of their biosynthesis or their regulation (7). Kamdar et al. (13) reported the isolation of three nonoverlapping classes of genomic cosmid clones from a library of P. syringae pv. phaseolicola that complements 1 UV-induced and 80 ethyl methanesulfonate-induced Tox-mutants. A representative clone from class III (pDC938) does not contain a gene(s) involved in phaseolotoxin production but restores the Tox+ phenotype to these mutants by nonallelic complementation. Subsequently, Rowley et al. (32) demonstrated that a 485-bp sequence in the insert of pDC938 was involved in this complementation and that this sequence contains DNA binding sites * Corresponding author.
which specifically bind to a protein that is produced by P. syringae pv. phaseolicola at 28°C. They proposed that this protein was a putative repressor that is titrated by the DNA binding sites in the 485-bp fragment from pDC938.
Unlike pDC938, pHK120 (a class I clone) complements five chromosomal Tn5 mutants in addition to the UV-and ethyl methanesulfonate-induced mutants (13) . The complementation of all five TnS mutants by pHK120 suggested that its insert harbored a cluster of genes involved in phaseolotoxin production, because the Tn5 insertions in the mutants are located in different chromosomal EcoRI fragments. Peet et al. (30) previously isolated a genomic fragment from P. syringae pv. phaseolicola that contained genes involved in phaseolotoxin production as well as a gene involved in the production of a phaseolotoxin-resistant OCT (ROCT) encoded by the argK gene (9) . The argK gene is physically linked to and coordinately regulated with the phaseolotoxin genes by temperature (9, 26, 31) .
Here we describe the genetic characterization of the pHK120 insert, which was performed by Tn5 mutagenesis of pHK120, marker exchange in the chromosome of the wild-type strain, pair complementation analysis, and complementation of marker exchange mutants by subclones containing fragments from the pHK120 insert. We found that the insert from pHK120 harbors at least eight loci involved in the production of phaseolotoxin.
( (32) , except that the field strength was raised to 7.1 kV. To verify constructs, plasmid DNA was extracted from transconjugants and transformed into E. coli DH5a in order to segregate the plasmid of interest from indigenous plasmids in the transconjugant. Marker exchange in transconjugants was forced by withdrawing tetracycline from the media and by repeated subculturing of the transconjugants in the presence of kanamycin (8) . The marker exchange mutants were examined for tetracycline sensitivity and screened by the E. coli toxin bioassay (36) . Southern hybridization analysis of HindIll-or BamHI-digested genomic DNA from each marker exchange mutant was done by using the 32P-labeled internal fragment from Tn5 as a probe to verify the position of Tn5 in the homogenote. Appropriate pHK120::Tn5 plasmid DNA was used as the control.
DNA isolation and manipulation. Plasmid DNA was extracted by the rapid boiling method or by the alkaline lysis method (2) and purified by CsCl gradient centrifugation. Genomic DNA extraction and Southern hybridization were performed as previously described (13) , except when noted otherwise. DNA fragments for subcloning were isolated from low-melting-point agarose after electrophoresis and purified with the USBioclean kit (U.S. Biochemicals, Cleveland, Ohio). Restriction enzyme digestion and ligation of DNA were carried out by standard protocols (2) . Fig. 1 ) were tested for toxin production, and the genomic DNA prepared from two of these colonies was examined by Southern hybridization to verify the location of the TnS insertion. Twenty-eight marker exchange mutants (Fig. 1B, shaded arrowheads) failed to produce toxin, indicating that the TnS insertion in these mutants had interrupted genes necessary for toxin production. Eleven marker exchange mutants (Fig. 1B , open arrowheads) retained their ability to produce toxin, suggesting that the Tn5 insertions in these mutants were outside regions essential for toxin production. No marker exchange mutants with an expected Tn5 insertion in the chromosome were recovered from the region containing Tn5 insertions at T63, AB2, T13, B25, and C13 after two attempts (Fig. 1B , open circles). Although Ditta (5) reported that the frequency of secondary transposition of Tn5 in Rhizobium strains is low, Madrid et al. (16) found that the frequency of secondary transposition within a multicopy plasmid in E. coli was approximately 10%. It is possible that the frequency of secondary transposition of Tn5 in P. syringae pv. phaseolicola is higher than that reported for Rhizobium strains, and this may account for the lack of marker exchange of the five Tn5 insertions into the chromosome. In summary, the TnS insertions that affected toxin production were distributed across most of the 25-kb insert of pHK120 and fell into four regions separated by small gaps where Tn5 insertions did not affect toxin production.
RESULTS
Three TnS mutants, TNM5, TNM7, and TNM11, previously obtained by random Tn5 mutagenesis of the chromosome of the wild-type strain (13) , were complemented by pHK120, implying that the Tn5 insertions were located within the chromosomal region represented by the insert in pHK120. Southern blots of the genomic DNA from the three TnS mutants were probed with 32P-labeled pHK120 DNA, and a comparison of the size of the hybridizing genomic fragments from the three mutants with that of pHK120 revealed that the insertions were located within the pHK120 region at the positions denoted by the symbol # (Fig. 1B) .
Fine mapping of transcriptional loci involved in toxin production. In order to fine map the transcriptional loci within the pHK120 insert, nine Tox-marker exchange mutants (one to four per region) (listed in Table 2 and indicated in Fig. 1B by the symbol *) and one random Tn5 mutant (TNM7) ( Table   2 and Fig. 1B ) were chosen for complementation by pHK120::TnS hybrid plasmids. Since these experiments involved a pair of Tn5 insertions (one in the chromosome of the mutant and one in the hybrid plasmid) in the transconjugants, they are referred to as pair complementation experiments. If the resulting transconjugant produced toxin, we concluded that the location of the TnS in the hybrid plasmid was outside the insertionally inactivated transcriptional unit in the mutant. However, if a hybrid plasmid failed to complement the mutant, the location of TnS in the pHK120::TnS plasmid was assumed to be within the insertionally inactivated transcriptional unit. To ensure that recombination had not occurred in these transconjugants, the plasmids were retrieved from the transconjugants, transformed into E. coli DH5cx, and examined by restriction enzyme digestion. The results of marker exchange mutagenesis and pair complementation showed that the insert in pHK120 harbors a minimum of eight transcriptional loci involved in toxin production (designated phtA through phtiH (Fig. 1B) .
(i) The phtA locus. Since hybrid plasmids containing Tn5 insertions at positions AF4, A46, A41, and A13 (Fig. iB) (ii) The phtB, phtC, and phtD loci. The second Tox -region, encompassing a 6.7-kb region between C37 and D19 (Fig. 1B) , was divided into three transcriptional units on the basis of pair complementation experiments (Table 2) . HOA7, TNM7, HOEI, and HOE4 contained Tn5 insertions within the same locus, phtB, whereas HOE8, HOE27, HOE47, and HOA25 contained the TnS in another locus, phtC. HOA4 contained a Tn5 in a third locus, phtD. The left border of the phtB locus is delimited by a Tox+ mutant, HOC37. The boundary between the phtB locus and the phtC locus is approximately placed between E4 and E8, two Tn5 insertions that are located at the far right of the phtB locus and the far left of the phtC locus. The right boundary of the phtC locus could not be determined because of a lack of Tn5 insertions in that region. However, the fact that a subclone, pYZB302, complemented the Toxmutant HOA25 (see below) indicates that the right boundary of the phtC locus is to the left of the third BamHI site. Similarly, the left boundary of the phtD locus is located right of the fourth SstI site, whereas its right boundary is delimited by a Tox+ mutant, HOD19.
(iii) The phtE, phtF, and phtG loci. Another Tox-region, encompassing an 8.0-kb region between C7 and G4 (Fig. 1B) , consists of three transcriptional units designated phtE, phtF, and phtG, respectively ( left and right sides, respectively, delimited the boundaries of this locus. It was surprising that pHK120::Tn5 plasmids containing TnS insertions at positions A47, A31, and A5 that mapped within the phtG locus (Fig. IB) failed to restore toxin production to marker exchange mutant HOH5, whereas HOA5 containing pHK120::Tn5 plasmids with Tn5 insertions in the phtH locus (Al and H5) did produce the toxin (Table 2) pHK120::Tn5-B25 pHK120::Tn5-AF4 pHK120::Tn5-A46 pHK120::Tn5-A41 pHK120::Tn5-A13 pHK120::Tn5-Al8 pHK120::Tn5-B5 pHK120::TnS-C37 pHK120::TnS-A7 pHK120::Tn5-E4 pHK120::TnS-E4 pHK120::Tn5-E8 pHK120::Tn5-E27 pHK120::Tn5-E47 pHK120::Tn5-A25 pHK120::Tn5-A4 pHK120::TnS-D19 pHK120::Tn5-A2 pHK120::TnS-C7 pHK120::TnS-A14 pHK120::Tn5-E17 pHK120::TnS-G1 pHK120::Tn5-A21 pHK120::Tn5-D23 pHK120::TnS-D13 pHK120::Tn5-C25 pHK120::Tn5-D18 pHK120::Tn5-C28 pHK120::Tn5-B36 pHK120::Tn5-D9 pHK120::Tn5-A47 pHK120::Tn5-A31 pHK120::TnS-A5 pHK120::Tn5-G4 pHK120::TnS-TP7 pHK120::Tn5-H5 pHK120::Tn5-A1 pHK120::Tn5-B1 pHK120::Tn5-A19 left of A47, i.e., in the phtF locus, complemented the mutants with mutations in the phtH locus. These results suggest that the phtG locus is required for the phtH locus to be functional.
Complementation of selected mutants by subclones of pHK120. Selected HindlIl, BamHI, PstI, and SstI fragments from pHK120 were cloned into the broad-host-range vectors pLAFR3, pRK404, and pLAFR376 and mobilized into one or more of the marker exchange mutants or the random chromosomal TnS mutants by electroporation or conjugation (Table 2 and Fig. 1C) . The plasmid pYZB2102, containing the 4.9-kb BamHI (B21) fragment (Fig. 1A and C) , restored toxin production to the marker exchange mutants HOA41 and HOA46, which contain mutations in the phtA locus. The phtB locus, represented by the mutant TNM7, was not complemented by either the plasmid pYZB2102 or the plasmid pYZH302, containing the 4.9-kb BamHI (B21) or the 4.3-kb HindIII (H3) fragment, respectively (Fig. 1A and C) . Therefore, the phtB locus must extend beyond the third HindIII site in pHK120 (Fig. 1A) . The plasmid pYZB302, containing a 2.2-kb BamHI (B3) fragment (Fig. 1A and C) , partially complemented HOA25 ( Fig. 1A and C) , and fully complemented (i.e., it produced toxin at levels equivalent to those produced by the wild-type strain) by the plasmid pYZST102, which contains the 8.6-kb SstI (Stl) fragment from pHK120 ( Fig. 1A and C) . Surprisingly, the plasmid pYZB2202, which contains the 4.9-kb BamHI (B22) fragment (Fig. 1A and C) , failed to complement HOA4. The Tox -mutants with mutations in the phtE locus, which spans a region of about 6.4 kb, according to the pair complementation analysis should have been complemented by the 8.6-kb SstI (Stl) fragment (Fig. 1A and C) , which covers the putative phtE locus. However, mutants HOA14 and HOC25 were not complemented by pYZST102. Three other plasmids, pYZH102, containing the 7.0-kb HindlIl (Hi) fragment; pYZB102, containing the 7.8-kb BamHI (Bi) fragment (Fig. 1A and C) ; and pYZP102, containing the 8.2-kb PstI (P1) fragment (Fig. IA and C) , also failed to complement HOC25. Both pYZB102 and pYZP102 complemented the marker exchange mutant HOB36, which contains a mutation in the phtF locus, whereas pYZH102 failed to do so, suggesting that the right boundary of the phtF locus extends beyond the sixth HindIII site. On the basis of the pair complementation analysis, the phtG and phtH loci are located within the B1 or P1 fragment of the pHK120 insert (Fig. 1A) . However, the plasmids pYZB102 and pYZP102, containing the Bi and P1 fragments, respectively, failed to complement marker exchange mutants HOA31 and HOH5, two mutants with Tn5 insertions in the phtG locus and the phtH locus, respectively ( Fig. 1A and C) .
A comparison of the genomic fragments from pHK120 and pRCP17. Previously, Peet et al. (30) reported that pRCP17, a cosmid containing -24 kb of genomic DNA from P. syringae pv. phaseolicola, harbors the ROCT gene and restores toxin production to several random Tn5 Tox-mutants obtained by them. Restriction analysis of the DNA from both plasmids and Southern blot hybridization with pRCP17 as the probe revealed that these two clones have overlapping inserts (Fig. 1D) . pHK120 contains about 4.8 kb of DNA (Fig. ID, H4 and part of H3) at the left end of its insert which is not present in pRCP17, whereas pRCP17 harbors about 5 kb of DNA which is not present in the insert of pHK120.
Because pRCP17 contains the ROCT gene (31), transformants of E. coli HB101 containing pRCP17 show resistance to phaseolotoxin. However, the transformants of E. coli HB101 containing pHK120 remained sensitive to the toxin (data not shown), indicating that this plasmid does not contain the ROCT gene. Thus, we conclude that the ROCT gene must be located within the 5-kb DNA fragment in pRCP17 that is not present in pHK120. pHK120 and thermoregulation of phaseolotoxin production. P. syringae pv. phaseolicola produces phaseolotoxin at 18°C, the optimum temperature for disease development, but not at 28°C or higher, the optimum temperature for growth (11) . Transconjugants of the wild-type strain G50-1 containing pHK120, however, produced toxin at the nonpermissive temperature (28°C). The level of toxin produced by the transconjugants at 28°C was equal to that produced by the wild-type strain at the permissive temperature (18°C), and the transconjugants grown at 18°C produced toxin at a level roughly three times that produced by the controls. Transconjugants of the Tox-mutant, G50-1UV, containing pHK120 also produced toxin at 28°C, although less than when grown at 18°C.
DISCUSSION
We have shown that a P. syringae pv. phaseolicola genomic clone (pHK120) which complements all Tox-mutants in our possession can be divided into at least eight complementation groups. Peet et al. (30) previously reported that some of the genes involved in phaseolotoxin production are clustered. The comparison of pHK120 with one of their clones (pRCP17) in this study indicated that the two clones differ from each other in only two respects: unlike pRCP17, pHK120 does not harbor the ROCT gene, and pHK120 contains a region of DNA (Fig.  1D, fragment H4 and part of H3) that is not shared by pRCP17. The genes for biosynthesis of many antibiotics, viz., bialaphos, are clustered (27) . Genes involved in the production of phytotoxins, such as syringomycin and syringotoxin (7, 24, 25, 39) produced by P. syringae pv. syringae, coronatine (22, 40) produced by P. syringae pv. tomato, and tabtoxin (15, 38) produced by P. syringae pv. tabaci, have also been reported to be clustered. Martin and Liras (17) have suggested that clustering of genes involved in the biosynthesis of secondary metabolites may be related to the sequential formation of the enzymes involved in the biosynthesis of these metabolites.
No leaky mutants were identified in this study, in contrast to the finding of Peet et al. (30) , who reported several randomly generated chromosomal Tn5 mutants that were leaky. This suggests that the products of the genes in the eight complementation groups are directly involved in toxin production. Toxin production was restored to the level produced by the wild-type strain in transconjugants of mutants HOA41 and HOA46 (with mutations in the phtA locus) containing pYZB2102 and in transconjugants of mutant HOB36 (with a mutation in the phtF locus) containing plasmid pYZB102 as well as plasmid pYZP102, indicating that sufficient information to fully express the gene(s) in the phtA and phtF loci is present in the respective subclones. Mutants with mutations in the phtC locus were only partially complemented by the plasmid pYZB302, although this plasmid contained -0.9 kb of DNA to the left of TnS insertion E8 and -0.4 kb of DNA to the right of Tn5 insertion A25 in the phtC locus. The simplest explanation for this result may be that the promoter for the gene(s) in this region is not present in the subclone and that the low level of expression of the gene(s) is the result of a read-through from the vector promoter. It is also possible that the transcriptional unit contains a single gene and that the 3' end of the gene is not present in the subclone, which results in the production of a truncated product that is only partially active.
Partial complementation was also obtained in a phtD mutant, HOA4, when subclone pYZH202 was mobilized into this mutant. Surprisingly, this mutant was not complemented by pYZB2202 but was fully complemented by pYZST102, a plasmid containing less DNA overlapping with the insert in pYZH202 than pYZB2202 did but containing an additional region of DNA to the right of the B22 fragment (Fig. 1A) . The test for complementation of HOA4 by these three subclones was repeated (data not shown), and the same results were obtained. Furthermore, restriction analysis of the plasmid constructs in the transconjugants showed that they were not altered. Although the reason for these unexpected complementation results is not known, the fact that pYZST102 fully restores toxin production in mutant HOA4 suggests that a trans-acting activator may be required for the phtD locus to function.
Although the original cosmid clone (pHK120) was able to complement mutants with mutations in the phtB, phtE, phtG, and phtH loci, none of the subclones shown in Fig. 1C complemented these mutants. We expected this with regard to the phtB locus because none of the subclones contained the entire predicted locus. However, on the basis of pair complementation analysis, the insert in pYZST102 should have complemented the phtE mutants (HOA14 and HOC25) . The fact that such complementation did not occur raises the possibility that pYZST102 does not contain the entire phtE locus. We have recently sequenced 6.7 kb of DNA (41) encompassing this locus, and preliminary analysis shows that the fifth SstI site (Fig. IA) interrupts a putative open reading frame (ORF). If this ORF is part of the phtE locus, then this locus must be larger than the predicted one (Fig. IB) , and this may explain why pYZST102 does not complement the phtE mutants (41) . A similar discrepancy between complementation analysis and sequencing data was reported by Jacobs et al. (12) for nodulation genes in Rhizobium meliloti. We also found that there is a gap of 200 bp between the ORF mentioned above and the one adjacent to it, and a sequence showing homology with the E. coli canonical promoter (10) is located in this gap, making it possible that the ORF interrupted by the fifth SstI site is part of the phtF locus. If this is the case, the reason for the failure of the first Sstl fragment to complement the mutants with mutations in this locus may have to do with the lack of a trans-acting positive regulatory factor, which is located outside this fragment. Alternatively, the increase in copy number of the genes in the subclone may lead to an accumulation of toxic intermediates in the transconjugant, which could downregulate toxin synthesis by a feedback mechanism.
The last two loci, phtG andphtH, are located in the BI or the P1 fragment of pHK120 according to pair complementation analysis. However, neither pYZB102 nor pYZP102 complemented the mutants with mutations located in these two loci, even though the inserts in both of these plasmids contain substantial regions of DNA on either side of these loci. Currently, we have no explanation for this unexpected result. Pair complementation analysis also indicated that the pHK120::Tn5 hybrid plasmids containing TnS insertions within the phtG locus failed to complement the phtH mutants, but pHKI20::Tn5 hybrid plasmids containing Tn5 insertions within the phtH locus complemented the phtG mutant, indicating that the phtG locus is required for the function of the phtH locus. This is similar to the relationship between syrD and syrB (7), two genes involved in the production of syringomycin by P. syringae pv. syringae, in which syrD regulates the transcription of syrB and the production of five high-molecular-weight proteins which have been shown to be involved in syringomycin production. It is also possible that the phtG and phtH loci constitute one locus and that the two Tox+ mutants with mutations between the phtG and phtH loci are nonpolar mutants.
Although pHK120 contains most of the genes involved in the production of phaseolotoxin, we conclude that it does not contain all of them. This conclusion is based on the fact that the transformants of E. coli containing pHK120 grew on minimal media (data not shown). Since pHK120 does not contain the ROCT gene and E. coli is sensitive to phaseolotoxin, production of the toxin should have resulted in growth inhibition of the transformants of E. coli on minimal media. Another observation which supports our conclusion that pHK120 does not contain all the toxin genes is that the transconjugants of P. syringae pv. syringae containing pHK120 did not produce toxin when tested in the E. coli toxin bioassay (data not shown).
Transconjugants of the wild-type P. syringae pv. phaseolicola (G50-1) containing pHK120 produced more toxin than the wild-type strain at 18°C, the permissive temperature. This increase in toxin production may imply that an activator gene is located in the pHK120 insert. Activators are involved in the biosynthesis of bialaphos (1, 27) , tylosin, actinorhodin, and streptomycin (17) produced by Streptomyces hygroscopicus, Streptomyces fradiae, Streptomyces coelicolor, and Streptomyces grisean, respectively. Transconjugants of the wild-type strain of S. coelicolor (actinorhodin positive) containing a cosmid clone that harbors an activator gene produced 30-to 40-fold more actinorhodin (17) . It is also possible that the gene cluster in the pHK120 insert contains a gene encoding a rate-limiting product involved in the synthesis of phaseolotoxin. Multiple copies of such a gene would result in higher-than-normal levels of this product and lead to increased levels of toxin in the transconjugants.
The fact that transconjugants containing pHK120 produced toxin at 28°C indicated that the thermoregulation of toxin production was overridden by pHK120. As mentioned above, if the pHK120 insert contains an activator, overproduction of this activator may abolish thermoregulation. However, a more likely explanation is that some or all of the phaseolotoxin genes present in pHK120 harbor DNA binding sites which titrate the putative repressor protein produced by P. syringae pv. phaseolicola at 28°C. A similar explanation for the production of phaseolotoxin by transconjugants of the wild-type strain containing pDC938, a class III genomic clone from P. syringae pv. phaseolicola, was previously proposed (32) . This clone does not harbor a structural or regulatory gene involved in toxin production but contains DNA binding motifs similar to those involved in binding proteins in other systems (34) . Rowley et al. (32) showed that at 28°C, the wild-type strain produces a protein(s) that specifically binds to a 485-bp fragment from the pDC938 insert that contains the DNA binding motifs. On the basis of these results, it was proposed that when present in multiple copies, the fragment harboring DNA binding sites titrates a repressor protein produced at 28°C, thereby allowing toxin biosynthesis to occur. Similar DNA binding motifs are found in the upstream region of the argK gene of P. syringae pv. phaseolicola (9) ; the argK gene is coordinately regulated with phaseolotoxin genes by temperature (9) . Recent results from our laboratory (33) have shown that an -490-bp fragment from the argK promoter region also specifically binds to a protein(s) produced by the wild-type strain at 28°C. We are currently examining the DNA sequence of the phtE locus to determine whether homologous sequences that bind to the putative repressor protein exist in the genes in this region.
The elucidation of the genetic organization of the cluster in pHK120 described above makes it possible to determine the number of genes in the cluster and their nucleotide sequences, to obtain their gene products, and to determine which of these genes are thermoregulated. These studies are currently under way. In the longer term, the availability of site-directed mutants will allow us to elucidate the pathway of biosynthesis of phaseolotoxin by determining the biosynthetic steps that are blocked in the various marker exchange mutants.
